Abstract
We recently demonstrated direct evidence of increased monoamine oxidase (MAO) activity in the brain of a simian immunodeficiency virus (SIV) model of human immunodeficiency virus (HIV)-associated central nervous system (CNS) disease, consistent with previously reported dopamine deficits in both SIV and HIV infection. In this study, we explored potential mechanisms behind this elevated activity. MAO B messenger RNA was highest in macaques with the most severe SIV-associated CNS lesions and was positively correlated with levels of CD68 and GFAP transcripts in the striatum. MAO B messenger RNA also correlated with viral loads in the CNS of SIV-infected macaques and with oxidative stress. Furthermore, in humans, striatal MAO activity was elevated in individuals with HIV encephalitis, compared with activity in HIV-seronegative controls. These data suggest that the neuroinflammation and oxidative stress caused by SIV infection in the CNS may provide the impetus for increased transcription of MAO B and that MAO, and more broadly, oxidative stress, have significant potential as therapeutic targets in CNS disease due to HIV. © The Author 2014.
Author supplied keywords
Cite
CITATION STYLE
Meulendyke, K. A., Ubaida-Mohien, C., Drewes, J. L., Liao, Z., Gama, L., Witwer, K. W., … Zink, M. C. (2014). Elevated brain monoamine oxidase activity in SIV-and HIV-associated neurological disease. In Journal of Infectious Diseases (Vol. 210, pp. 904–912). Oxford University Press. https://doi.org/10.1093/infdis/jiu194
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.